ESR1 and breast cancer: Kaplan-Meier analysis revealed that ER+ breast cancer patients with high HIF-1α expression had a worse prognosis compared to those with low HIF-1α expression; while, in ER- breast cancer patients, HIF-1α expression was weakly associated with prognosis (Fig. S8).